Showing 111-120 of 855 results for "".
A Nose for Disease: A Review of Olfactory-Based Diagnosis in Dermatology
https://practicaldermatology.com/topics/infections-infectious-disease/a-nose-for-disease-a-review-of-olfactory-based-diagnosis-in-dermatology/23650/Despite technological advancements in diagnosis, the sense of smell can still be a helpful tool in the medical clinic.Look to the EAST: Shared Decision Making in the Era of New Therapies
https://practicaldermatology.com/topics/atopic-dermatitis/look-to-the-east-shared-decision-making-in-the-era-of-new-therapies/23372/Assessing Efficacy, Accessibility, Safety, and Tolerability is the key to a meaningful dialogue with patients.Let’s Talk About Truncal Acne
https://practicaldermatology.com/topics/acne-rosacea/lets-talk-about-truncal-acne/23785/A look at the burden of truncal acne and current treatment options.First Reported Case of Red Face Response to Tralokinumab in the United States
https://practicaldermatology.com/issues/september-2025/first-reported-case-of-red-face-response-to-tralokinumab-in-the-united-states/37639/The chronic nature of atopic dermatitis (AD), which currently affects approximately 10.8% of children and 7.3% of adults in the United States,1 makes long-term management challenging.Stirring the Pot: Cannabinoids and Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/stirring-the-pot-cannabinoids-and-atopic-dermatitis/20565/Cannabinoids are a diverse group of compounds that may hold significant therapeutic capabilities applicable to many areas of medicine, including dermatology.Understanding a New Method of Assessing Psoriasis Severity
https://practicaldermatology.com/columns/clinical-focus-1/understanding-a-new-method-of-assessing-psoriasis-severity/23157/New method aims to improve access to systemic psoriasis therapy.Phase 2 and 3 Trials of JAK Inhibitors For Atopic Dermatitis: A Review
https://practicaldermatology.com/topics/atopic-dermatitis/phase-2-and-3-trials-of-jak-inhibitors-for-atopic-dermatitis-a-review/23265/A number of drugs in development show promise for one of the most challening skin diseases.New in My Practice: Serum/New Products
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-in-my-practice-serumnew-products/23888/Pipeline and Potential Roles for GLP-1RAs in Dermatology
https://practicaldermatology.com/issues/novemberdecember-2025/pipeline-and-potential-roles-for-glp-1ras-in-dermatology/48898/Having reviewed the mechanism of action and current roles in medicine for glucagon-like peptide 1 receptor agonists (GLP-1RAs), we now can discuss therapies in this class currently under investigation for management of dermatologic disease.Rising Skin Cancer Rates are a Global Reality
https://practicaldermatology.com/topics/general-topics/PD1009_04-php/20367/One group of researchers questions the skin cancer epidemic, but the overwhelming evidence suggests that rates are rising.